TY  - JOUR
AU  - Olivares-Hernandez, Alejandro
AU  - Del-Barco-Morillo, Edel
AU  - Miramontes-Gonzalez, Jose Pablo
AU  - Figuero-Perez, Luis
AU  - Perez-Belmonte, Luis
AU  - Martin-Vallejo, Javier
AU  - Martin-Gomez, Teresa
AU  - Escala-Cornejo, Roberto
AU  - Vidal-Tocino, Rosario
AU  - Bellido-Hernandez, Lorena
AU  - Gonzalez-Sarmiento, Rogelio 
AU  - Ludeña-de-la-Cruz, Maria Dolores
AU  - Cruz-Hernandez, Juan Jesus
AU  - Parra-Perez, Carmen 
PY  - 2022
DO  - 10.31083/j.fbl2703088
UR  - http://hdl.handle.net/10668/21810
T2  - Frontiers in bioscience (Landmark edition)
AB  - Determining predictive biomarkers for immune checkpoint inhibitors (ICIs) is a current challenge in oncology. Previous studies on non-small cell lung cancer (NSCLC) have shown how TP53 gene mutations are correlated with different responses to ICIs....
LA  - en
PB  - IMR Press
KW  - Biomarkers
KW  - Immune checkpoint inhibitors
KW  - Immunotherapy
KW  - Non-small cell lung cancer
KW  - p53 protein
KW  - Adenocarcinoma
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - B7-H1 Antigen
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Female
KW  - Humans
KW  - Immunotherapy
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Tumor Suppressor Protein p53
TI  - Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy.
TY  - research article
VL  - 27
ER  -